Law360 - The Newswire for Business Lawyers
Sign In
 

Try our Advanced Search for more refined results

Law360
  • Search Law360
  • Search News Only
  • Search Cases Only
  • Search PTAB Only
  • Search TTAB Only
  • Advanced Search
  Sign In

Law360

|

The Practice of Law

Access to Justice Aerospace & Defense Appellate Asset Management Banking Bankruptcy Benefits California Cannabis Capital Markets Class Action Colorado Commercial Contracts Competition Compliance Connecticut Construction Consumer Protection Corporate Criminal Practice Cybersecurity & Privacy Delaware Employment
Energy Environmental Fintech Florida Food & Beverage Georgia Government Contracts Health Hospitality Illinois Immigration Insurance Intellectual Property International Arbitration International Trade Legal Ethics Legal Industry Life Sciences Massachusetts Media & Entertainment Mergers & Acquisitions Michigan Native American
New Jersey New York North Carolina Ohio Pennsylvania Personal Injury & Medical Malpractice Private Equity Product Liability Project Finance Public Policy Real Estate Retail & E-Commerce Securities Sports & Betting Tax Technology Telecommunications Texas Transportation Trials Washington White Collar

Law360 Pulse

|

Business of Law

California Pulse Connecticut Pulse Courts DC Pulse Daily Litigation Delaware Pulse
Florida Pulse Georgia Pulse In-House Insights Legal Tech & AI Mid-Law
Modern Lawyer New Jersey Pulse New York Pulse Pennsylvania Pulse Small Law Texas Pulse

Law360 Authority

|

Deep News & Analysis

Tax Authority

Federal International State & Local

Employment Authority

Discrimination Labor Other Wage & Hour

Insurance Authority

General Liability Other Property Specialty Lines

Real Estate Authority

Commercial Other Residential

Bankruptcy Authority

Large Cap Mid Cap

Healthcare Authority

Deals & Corporate Governance Digital Health & Technology Other Policy & Compliance

Global

Law360 UK

Commercial Litigation UK Corporate Crime & Compliance UK Employment UK Financial Services UK Insurance UK Intellectual Property UK Pulse UK Transactions UK
Close
  • Law360
  • Law360 UK
  • Law360 Pulse
  • Law360 Employment Authority
  • Law360 Tax Authority
  • Law360 Insurance Authority
  • Law360 Real Estate Authority
  • Law360 Healthcare Authority
  • Law360 Bankruptcy Authority
  • Products
  • Lexis®
  • Law360 Tax Authority
  • Law360 In-Depth
  • Law360 Podcasts
  • Rankings
  • Leaderboard Analytics
  • Regional Powerhouses
  • Law360's MVPs
  • Women in Law Report
  • Law360 400
  • Diversity Snapshot
  • Practice Groups of the Year
  • Rising Stars
  • Titans of the Plaintiffs Bar
  • Sections
  • Adv. Search & Platform Tools
  • About all sections
  • Browse all sections
  • Banking
  • Bankruptcy
  • Class Action
  • Competition
  • Employment
  • Energy
  • Expert Analysis
  • Insurance
  • Intellectual Property
  • Product Liability
  • Securities
  • Beta Tools
  • Track docs
  • Track attorneys
  • Track judges
  • Site Menu
  • Join the Law360 team
  • Search legal jobs
  • Learn more about Law360
  • Read testimonials
  • Contact Law360
  • Sign up for our newsletters
  • Law360 Company
  • About Law360 Authority
  • Resource Library
  • Site Map
  • Help
CaseMap® CLE On-Demand Context CourtLink® Digital Library Intelligize Law360 Lex Machina Lexis Medical Navigator™ Lexis® Lexis+™
Lexis® Tax MLex® MLex® (New) Nexis® Nexis Diligence™ Nexis Newsdesk™ Practical Guidance Product Liability Navigator Securities Mosaic® State Net® Verdict & Settlement Analyzer
Intellectual Property Securities Bankruptcy Competition Employment White Collar Legal Industry Artificial Intelligence Law360 UK Pulse || See all sections ||
 
 
 
What does job satisfaction mean to you?
Click here to take the Law360 survey

Novartis To Buy US Biotech In Up-To-$2B Allergy Drug Deal

Logo of a Swiss pharmaceutical giant appears on the screen with a medical syringe.

By Najiyya Budaly

Swiss pharmaceutical giant Novartis AG said Friday that it will buy Excellergy, a U.S. biotechnology company, for up to $2 billion as it seeks access to a therapy to combat allergic reactions.


Read Full Article

 
 
 
Promo that reads 2025 Practice Groups of the Year
 
 
 


Promo that reads 2025 MVPs
 
 
 


Promo that reads Law360 Pulse Compensation Report
 
 
 


Promo that reads Law360 Pulse Leaderboard
 
 
 


Promo that reads Guide to Trump's Judicial Picks with a map showing the number of vacancies in the district courts
Promo that reads 2025 Law360 Regional Powerhouses
Promo that reads Law360 Pulse Associate Salary and Bonus Tracker with an image of hundred-dollar bills

Follow Law360 On Social Media

Top Stories
  • Smartphone screen displaying the text ANTHROPIC AI in bold white letters. In the background, there is a blurred seal of the U.S. Department of Defense
    Anthropic Blocks Pentagon's 'Orwellian' Security Risk Label

    By Hailey Konnath

    A California federal judge Thursday issued a preliminary injunction barring the Trump administration from labeli...(read more)

  • Exterior signage at a Wells Fargo location that shows the bank name in yellow lettering at the roofline of the building.
    2nd Circ. Reopens Mortgage-Backed Securities ERISA Suit

    By Kellie Mejdrich

    The Second Circuit on Thursday revived a federal benefits lawsuit against Wells Fargo and Ocwen accusing the com...(read more)

  • House GOP Faces Hurdles Passing Senate DHS Funding Deal

    By Courtney Bublé

    After the Senate passed by voice vote in the early hours of Friday morning a bill to fund most of the U.S. Department of Homeland Security except the immigration components, the challenge could be getting it through the House.

  • Live Nation Kicks Off Defense Case In Antitrust Trial

    By Stewart Bishop

    A coalition of state attorneys general on Thursday mostly concluded their antitrust case against Live Nation and its Ticketmaster subsidiary, following weeks of a trial that was nearly derailed after the U.S. Department of Justice dropped out, and Live Nation kicked off its defense case with a company executive who pushed back against claims of anticompetitive conduct.

  • Elon Musk Slams Twitter Stock Verdict Over Jury's $4.20 'Joke'

    By Lauren Berg

    Elon Musk did not get a fair trial over claims he defrauded Twitter investors before acquiring the social media platform, the tech billionaire's lawyer told a California federal judge Thursday, saying the jury rolled a marijuana "joke" into the verdict form to mock Musk and the trial process.

  • ITC Domestic Industry Rules Keep Opening Up In Apple Case

    By Ryan Davis

    A Federal Circuit decision upholding a U.S. International Trade Commission exclusion order on the Apple Watch in a patent dispute with Masimo has again eased hurdles for patent owners aiming to make the ITC's required showing that they have domestic industry, attorneys say.

  • X Corp.'s Lack Of Antitrust Injury Dooms Ad Boycott Suit

    By Rae Ann Varona

    A Texas federal judge Thursday dismissed X Corp.'s sprawling antitrust suit that accused several advertisers of unlawfully boycotting the Elon Musk-owned social media company by substantially cutting back on or stopping ad purchases, saying X didn't suffer any antitrust injury.

  • White & Case Staffer Sues Firm Over Nude Photo Ridicule

    By Dorothy Atkins

    A White & Case LLP staffer sued the law firm in New York state court Wednesday, alleging the firm's purported "hostile work environment" shielded his colleagues after they allegedly shared nude photos of him, which he claims were taken by his supervisor while he was unconscious at a firm-sponsored party.

  • States Will Fill DOJ, FTC's Antitrust Void, Ill. AG Atty Says

    By Bryan Koenig

    The top antitrust attorney at the Illinois attorney general's office predicted Thursday that state enforcers will continue to pick up the pace as the Federal Trade Commission and especially the U.S. Department of Justice's Antitrust Division "become less transparent and less active."

  • Fed. Circ. Rejects Pharma Co. Refiling Suit To Reset Deadline

    By Dani Kass

    Ascendis Pharma missed its window to invoke a mandatory stay in California federal court based on parallel U.S. International Trade Commission proceedings, and its attempt to reset the patent litigation doesn't change that, the Federal Circuit said Thursday.

  • FTC Antitrust Head Cites Acquihire 'Tension' With Deal Rule

    By Bryan Koenig

    The Federal Trade Commission's top antitrust official said Thursday that so-called reverse acquihires appear designed solely to avoid merger reporting requirements, while noting that competition enforcers continue to scrutinize the deals that are newly popular in Silicon Valley, especially in the artificial intelligence space.

  • Akin Must Explain Client's 'Self-Indulgent' 9th Circ. Appeal

    By Lauren Berg

    Upholding a foreign arbitration award against a wine importer, the Ninth Circuit on Thursday ordered its attorneys at Akin Gump Strauss Hauer & Feld LLP to explain why they and their client shouldn't pay their opponent's attorney fees for bringing a "frivolous" and "self-indulgent" appeal.

  • Ketamine, WilmerHale Probe Off Limits In Musk-OpenAI Trial

    By Dorothy Atkins

    A California federal judge has placed evidentiary guardrails on an April jury trial over Elon Musk's claims OpenAI duped him, excluding evidence on Musk's ketamine use and WilmerHale's investigation into Sam Altman's dismissal, but allowing evidence on Musk's rival startup, his romance with an ex-OpenAI boardmember and his Burning Man trip.

  • 4 Key Questions On Tariff Investigations

    By Dylan Moroses

    The U.S. announced a bevy of new trade investigations this month to underpin a tariff regime intended to replace duties struck down by the U.S. Supreme Court, but questions remain about the fate of deals struck with trading partners and whether importers will face higher tariffs. Here, Law360 examines four questions on the implications of those investigations.

Promo that says AI The Latest Coverage with a photo of a person at a laptop with AI illustrations overlaid
 
 
 


Latest News

  • Pharma Co. Says Exec Was Fired Over Conduct, Not Piglets
  • CrossCountry Wins REIT Bidding Contest With All-Cash Deal
  • Colo. Nurses Snag Class Cert. In Holiday Pay Case
  • Family Members Get Prison Terms For Tax Refund Scheme
  • United Bank's $2M Deal In ESOP Suit Clears Final Hurdle
  • GAO Says OMB Should Give More AI Privacy Guidance
  • Jack In The Box Says Buyer Breached Del Taco Deal
  • Texas Calls Vape Sellers' Suit Over China Law 'Speculative'
  • Man Convicted Over Threats To Kill Trump, Burn Courthouse
  • REIT Investor Drops Suit Over $2.3B Deal Disclosures

From The Courtroom

  • Venezuelan Leader Says Ex-Fla. Rep Couldn't Get US Meetings
  • 'I Don't Know': 9th Circ. Presses Verrilli On Boeing Venue Issue
  • Oak View Exec Tells Jury Of Deal To Hype Ticketmaster
  • Co.'s Dual Citizenship Doesn't Kill Jurisdiction, 4th Circ. Told
  • Mom Tying Abbott Formula To Baby's NEC Takes The Stand
  • Convicted Ex-Budget Official's Attorney Resignation Approved
  • Teens Are Meta's 'Collateral Damage,' Jury Hears In Closings
  • Ex-Fla. Rep Paid To Secretly Lobby For Maduro, Jurors Told
  • Social Media Jurors Say They Are Deadlocked On A Defendant
  • Healthcare Co. Liable For Patient's Killings, Philly Jury Told
 
 
 

Expert Analysis

  • Manish Kumar
    What To Watch At The 2026 ABA Antitrust Spring Meeting
    Attorneys at Freshfields consider the future of antitrust law and competition among developments likely to dominate discussion at th... (read more)
  • Sean Tonolli
    How DOJ's New Corporate Crime Policy Will Work In Practice
    The upshot of the Justice Department's new corporate crimes enforcement framework is uniformity for self-reporting companies, but th... (read more)
  • Olga Berson
    Moderna Case Highlights Overlooked Hurdle In Biopharma IP
    The recent settlement of the patent litigation involving Moderna's COVID-19 vaccine in Delaware federal court shows that patent port... (read more)
  • Nerissa Hamilton-vom Baur
    How Bankrupt Cos. Can Seek Refunds For Illegal Tariffs
    In light of the U.S. Supreme Court's recent decision striking down President Donald Trump's International Emergency Economic Powers ... (read more)
  • J. Michael Showalter
    What Texas Anti-Boycott Ruling Means For ESG Landscape
    A Texas federal court's recent ruling in American Sustainable Business Council v. Hegar that Texas' anti-ESG law is unconstitutional... (read more)
  • Read More Expert Analysis

 
 
 

Want to publish in Law360?


Submit an idea
 
 
 

Have a news tip?


Contact us here
 
 
 


Image that reads 2026 Editorial Calendar

 
 
 


Corporate Responsibility: Racial Equality

RELX Group Lexis Nexis

© 2026, Portfolio Media, Inc. | About | Contact Us | Careers at Law360 | Terms | Privacy Policy | Trust Center | Cookie Settings | Processing Notice | Ad Choices | Help | Site Map | Resource Library | Law360 Company | Testimonials